Arthritis Monoclonal Antibodies Market Report

Global and Region Arthritis Monoclonal Antibodies Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 02, 2022
  • PAGES：207
  • REPORT CODE：GMM997563
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Arthritis Monoclonal Antibodies market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Arthritis Monoclonal Antibodiesmarket, defines the market attractiveness level of Arthritis Monoclonal Antibodies market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Arthritis Monoclonal Antibodies industry, describes the types of Arthritis Monoclonal Antibodies market, the applications of major players and the market size, and deeply analyzes the current situation of the global Arthritis Monoclonal Antibodies market and the development prospects and opportunities of Arthritis Monoclonal Antibodies industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Arthritis Monoclonal Antibodies market in Chapter 13.

    By Player:

    • Pfizer Inc

    • GSK

    • Genentech

    • Mylan

    • F Hoffmann-La Roche Ltd

    • Johnson & Johnson(Janssen)

    • AbbVie Inc

    • AstraZeneca PLC

    • Novartis

    By Type:

    • Remicade

    • Humira

    • Enbrel

    • Rituxan

    • Orencia

    • Actemra

    • Simponi

    • Cimzia

    By End-User:

    • Rheumatoid Arthritis

    • Osteoarthritis

    • Psoriatic Arthritis

    • Ankylosing Spondylitis

    • Fibromyalgia

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Arthritis Monoclonal Antibodies Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Arthritis Monoclonal Antibodies Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Arthritis Monoclonal Antibodies Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Arthritis Monoclonal Antibodies Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Arthritis Monoclonal Antibodies Market Analysis and Outlook to 2022

    • 7.1 Global Arthritis Monoclonal Antibodies Consumption (2017-2022)

    • 7.2 United States Arthritis Monoclonal Antibodies Consumption (2017-2022)

    • 7.3 Europe Arthritis Monoclonal Antibodies Consumption (2017-2022)

    • 7.4 China Arthritis Monoclonal Antibodies Consumption (2017-2022)

    • 7.5 Japan Arthritis Monoclonal Antibodies Consumption (2017-2022)

    • 7.6 India Arthritis Monoclonal Antibodies Consumption (2017-2022)

    • 7.7 South Korea Arthritis Monoclonal Antibodies Consumption (2017-2022)

    8 Region and Country-wise Arthritis Monoclonal Antibodies Market Analysis and Outlook to 2028

    • 8.1 Global Arthritis Monoclonal Antibodies Consumption Forecast (2022-2028)

    • 8.2 United States Arthritis Monoclonal Antibodies Consumption Forecast (2022-2028)

    • 8.3 Europe Arthritis Monoclonal Antibodies Consumption Forecast (2022-2028)

    • 8.4 China Arthritis Monoclonal Antibodies Consumption Forecast (2022-2028)

    • 8.5 Japan Arthritis Monoclonal Antibodies Consumption Forecast (2022-2028)

    • 8.6 India Arthritis Monoclonal Antibodies Consumption Forecast (2022-2028)

    • 8.7 South Korea Arthritis Monoclonal Antibodies Consumption Forecast (2022-2028)

    9 Global Arthritis Monoclonal Antibodies Market Outlook by Types and Applications to 2022

    • 9.1 Global Arthritis Monoclonal Antibodies Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Remicade Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Humira Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Enbrel Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Rituxan Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Orencia Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Actemra Consumption and Growth Rate (2017-2022)

      • 9.1.7 Global Simponi Consumption and Growth Rate (2017-2022)

      • 9.1.8 Global Cimzia Consumption and Growth Rate (2017-2022)

    • 9.2 Global Arthritis Monoclonal Antibodies Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Rheumatoid Arthritis Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Osteoarthritis Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Psoriatic Arthritis Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Ankylosing Spondylitis Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Fibromyalgia Consumption and Growth Rate (2017-2022)

      • 9.2.6 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Arthritis Monoclonal Antibodies Market Outlook by Types and Applications to 2028

    • 10.1 Global Arthritis Monoclonal Antibodies Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Remicade Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Humira Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Enbrel Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Rituxan Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Orencia Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global Actemra Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.7 Global Simponi Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.8 Global Cimzia Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Arthritis Monoclonal Antibodies Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Rheumatoid Arthritis Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Osteoarthritis Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Psoriatic Arthritis Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Ankylosing Spondylitis Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Fibromyalgia Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.6 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Arthritis Monoclonal Antibodies Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Arthritis Monoclonal Antibodies Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Arthritis Monoclonal Antibodies Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Arthritis Monoclonal Antibodies Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Arthritis Monoclonal Antibodies Market Competitive Analysis

    • 14.1 Pfizer Inc

      • 14.1.1 Pfizer Inc Company Details

      • 14.1.2 Pfizer Inc Arthritis Monoclonal Antibodies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Pfizer Inc Arthritis Monoclonal Antibodies Product and Service

    • 14.2 GSK

      • 14.2.1 GSK Company Details

      • 14.2.2 GSK Arthritis Monoclonal Antibodies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 GSK Arthritis Monoclonal Antibodies Product and Service

    • 14.3 Genentech

      • 14.3.1 Genentech Company Details

      • 14.3.2 Genentech Arthritis Monoclonal Antibodies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Genentech Arthritis Monoclonal Antibodies Product and Service

    • 14.4 Mylan

      • 14.4.1 Mylan Company Details

      • 14.4.2 Mylan Arthritis Monoclonal Antibodies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Mylan Arthritis Monoclonal Antibodies Product and Service

    • 14.5 F Hoffmann-La Roche Ltd

      • 14.5.1 F Hoffmann-La Roche Ltd Company Details

      • 14.5.2 F Hoffmann-La Roche Ltd Arthritis Monoclonal Antibodies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 F Hoffmann-La Roche Ltd Arthritis Monoclonal Antibodies Product and Service

    • 14.6 Johnson & Johnson(Janssen)

      • 14.6.1 Johnson & Johnson(Janssen) Company Details

      • 14.6.2 Johnson & Johnson(Janssen) Arthritis Monoclonal Antibodies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Johnson & Johnson(Janssen) Arthritis Monoclonal Antibodies Product and Service

    • 14.7 AbbVie Inc

      • 14.7.1 AbbVie Inc Company Details

      • 14.7.2 AbbVie Inc Arthritis Monoclonal Antibodies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 AbbVie Inc Arthritis Monoclonal Antibodies Product and Service

    • 14.8 AstraZeneca PLC

      • 14.8.1 AstraZeneca PLC Company Details

      • 14.8.2 AstraZeneca PLC Arthritis Monoclonal Antibodies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 AstraZeneca PLC Arthritis Monoclonal Antibodies Product and Service

    • 14.9 Novartis

      • 14.9.1 Novartis Company Details

      • 14.9.2 Novartis Arthritis Monoclonal Antibodies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Novartis Arthritis Monoclonal Antibodies Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Arthritis Monoclonal Antibodies

    • Figure Arthritis Monoclonal Antibodies Picture

    • Table Global Arthritis Monoclonal Antibodies Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Arthritis Monoclonal Antibodies Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Arthritis Monoclonal Antibodies Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Arthritis Monoclonal Antibodies Consumption by Country (2017-2022)

    • Figure United States Arthritis Monoclonal Antibodies Consumption and Growth Rate (2017-2022)

    • Table Europe Arthritis Monoclonal Antibodies Consumption and Growth Rate (2017-2022)

    • Figure China Arthritis Monoclonal Antibodies Consumption and Growth Rate (2017-2022)

    • Figure Japan Arthritis Monoclonal Antibodies Consumption and Growth Rate (2017-2022)

    • Figure India Arthritis Monoclonal Antibodies Consumption and Growth Rate (2017-2022)

    • Figure South Korea Arthritis Monoclonal Antibodies Consumption and Growth Rate (2017-2022)

    • Figure Global Arthritis Monoclonal Antibodies Consumption Forecast by Country (2022-2028)

    • Figure United States Arthritis Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Arthritis Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Arthritis Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Arthritis Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Arthritis Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Arthritis Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Remicade Consumption and Growth Rate (2017-2022)

    • Figure Global Humira Consumption and Growth Rate (2017-2022)

    • Figure Global Enbrel Consumption and Growth Rate (2017-2022)

    • Figure Global Rituxan Consumption and Growth Rate (2017-2022)

    • Figure Global Orencia Consumption and Growth Rate (2017-2022)

    • Figure Global Actemra Consumption and Growth Rate (2017-2022)

    • Figure Global Simponi Consumption and Growth Rate (2017-2022)

    • Figure Global Cimzia Consumption and Growth Rate (2017-2022)

    • Figure Global Rheumatoid Arthritis Consumption and Growth Rate (2017-2022)

    • Figure Global Osteoarthritis Consumption and Growth Rate (2017-2022)

    • Figure Global Psoriatic Arthritis Consumption and Growth Rate (2017-2022)

    • Figure Global Ankylosing Spondylitis Consumption and Growth Rate (2017-2022)

    • Figure Global Fibromyalgia Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Remicade Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Humira Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Enbrel Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Rituxan Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Orencia Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Actemra Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Simponi Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cimzia Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Rheumatoid Arthritis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Osteoarthritis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Psoriatic Arthritis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ankylosing Spondylitis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Fibromyalgia Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Arthritis Monoclonal Antibodies Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Arthritis Monoclonal Antibodies Export by Region (Top 5 Countries) (2017-2028)

    • Table Pfizer Inc (Foundation Year, Company Profile and etc.)

    • Table Pfizer Inc Arthritis Monoclonal Antibodies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Inc Arthritis Monoclonal Antibodies Product and Service

    • Table GSK (Foundation Year, Company Profile and etc.)

    • Table GSK Arthritis Monoclonal Antibodies Sales, Price, Value and Gross Profit (2017-2022)

    • Table GSK Arthritis Monoclonal Antibodies Product and Service

    • Table Genentech (Foundation Year, Company Profile and etc.)

    • Table Genentech Arthritis Monoclonal Antibodies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genentech Arthritis Monoclonal Antibodies Product and Service

    • Table Mylan (Foundation Year, Company Profile and etc.)

    • Table Mylan Arthritis Monoclonal Antibodies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mylan Arthritis Monoclonal Antibodies Product and Service

    • Table F Hoffmann-La Roche Ltd (Foundation Year, Company Profile and etc.)

    • Table F Hoffmann-La Roche Ltd Arthritis Monoclonal Antibodies Sales, Price, Value and Gross Profit (2017-2022)

    • Table F Hoffmann-La Roche Ltd Arthritis Monoclonal Antibodies Product and Service

    • Table Johnson & Johnson(Janssen) (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson(Janssen) Arthritis Monoclonal Antibodies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson(Janssen) Arthritis Monoclonal Antibodies Product and Service

    • Table AbbVie Inc (Foundation Year, Company Profile and etc.)

    • Table AbbVie Inc Arthritis Monoclonal Antibodies Sales, Price, Value and Gross Profit (2017-2022)

    • Table AbbVie Inc Arthritis Monoclonal Antibodies Product and Service

    • Table AstraZeneca PLC (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca PLC Arthritis Monoclonal Antibodies Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca PLC Arthritis Monoclonal Antibodies Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Arthritis Monoclonal Antibodies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Arthritis Monoclonal Antibodies Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US